Overview
- Peptide (C)KTTRPFKTSNPKNLLGAK, corresponding to amino acid residues 125-142 of human P2RY12 (Accession Q9H244). Intracellular, 2nd cytoplasmic loop.
- Western blot analysis of rat brain membranes (1 and 2) and human platelets (3 and 4):1,3. Anti-P2Y12 Receptor Antibody (#APR-012), (1:200).
2,4. Anti-P2Y12 Receptor Antibody, preincubated with P2Y12 Receptor Blocking Peptide (#BLP-PR012). - Western blot analysis of human platelets:1. Anti-P2Y12 Receptor Antibody (#APR-012), (1:200)
2. Anti-P2Y12 Receptor Antibody, preincubated with P2Y12 Receptor Blocking Peptide (#BLP-PR012).
- Mouse bone marrow lysate (Ribeiro-Filho, A.C. et al. (2016) BMC Pharmacol. Toxicol. 17, 29.).
- Expression of P2RY12 in mouse brainImmunohistochemical staining of mouse brain sections using Anti-P2Y12 Receptor Antibody (#APR-012), (red). The region shown in this picture is the entorhinal cortex in mouse brain. The P2Y12 positive fibers (arrows) run from the corpus callosum (triangles) into the deep layers of the entorhinal cortex. Sytox green is used as the counterstain.
- Rat astrocytes (1:50) (Carrasquero, L.M. et al. (2005) Purinergic Signal. 1, 153.).
- Rat osteoclasts (8 μg/ml) (Alvarenga, E.C. et al. (2010) Bone 46, 355.).
- The blocking peptide is not suitable for this application.
- Queiroz, G. et al. (2003) J. Pharmacol. Exp. Ther. 307, 809.
- Ralevic, V. and Burnstock, G. (1998) Pharmacol. Rev. 50, 413.
- Abbracchio, M.P. et al. (2003) Trends. Pharmacol. Sci. 24, 52.
- Nicholas, R.A. (2001) Mol. Pharmacol. 60, 416.
The P2Y receptors belong to the G-protein coupled receptor superfamily. They mediate the actions of the extracellular nucleotides (ATP, ADP, UTP and UDPA). Eight functional mammalian P2Y receptors have been described: P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, and the UDP-glucose receptor, now renamed P2Y14.1-3
The P2Y12 receptor is co-expressed with P2Y1 receptor on platelets leading to shape change, aggregation, and rise in intracellular Ca2+ upon activation.
The only other expression of P2Y12 was found in brain, according to results of reverse transcription-polymerase chain reaction and northern blotting.4 The P2Y12 receptor has become a target for potential therapeutic drugs for the treatment of thromboembolism and other clotting disorders.4
Application key:
Species reactivity key:
Anti-P2Y12 Receptor Antibody (#APR-012) is a highly specific antibody directed against an intracellular epitope of the human P2RY12. The antibody can be used in western blot, immunoprecipitation, indirect flow cytometry, immunohistochemistry and immunocytochemistry applications. It has been designed to recognize P2RY12 from human, rat, and mouse samples.
Expression of P2Y12 receptor in human eosinophils.A. Indirect flow cytometry of human eosinophils using Anti-P2Y12 Receptor Antibody (#APR-012). B. Immunocytochemical staining of human eosinophils using Anti-P2Y12 Receptor Antibody. P2Y12 immunostaining is shown in green. In both applications, preincubating the antibody with the blocking peptide abolishes the detection of the receptor.Adapted from Muniz, V.S. et al. (2015) PLoS ONE 10, e0139805. with permission of PLoS.
Applications
Citations
- Mouse bone marrow lysate.
Ribeiro-Filho, A.C. et al. (2016) BMC Pharmacol. Toxicol. 17, 29. - Rat heart lysate (1:200).
Giachini, F.R. et al. (2014) PLoS ONE 9, e91890.
- Mouse bone marrow lysate.
Ribeiro-Filho, A.C. et al. (2016) BMC Pharmacol. Toxicol. 17, 29.
- Human eosinophils.
Muniz, V.S. et al. (2015) PLoS ONE 10, e0139805. - Human fibroblasts (1:100).
Pinheiro, A.R. et al. (2013) J. Biol. Chem. 288, 27571. - Rat astrocytes (1:50).
Carrasquero, L.M. et al. (2005) Purinergic Signal. 1, 153.
- Human eosinophils.
Muniz, V.S. et al. (2015) PLoS ONE 10, e0139805.
- Human blood samples.
Ngo, A.T.P. et al. (2020) Platelets 131, 68. - Mouse bone marrow cells.
Ribeiro-Filho, A.C. et al. (2016) BMC Pharmacol. Toxicol. 17, 29. - Human eosinophils.
Muniz, V.S. et al. (2015) PLoS ONE 10, e0139805. - Rat osteoclasts (8 μg/ml).
Alvarenga, E.C. et al. (2010) Bone 46, 355.
- Frobel, J. et al. (2013) Mol. Cell. Proteomics 12, 1272.
- Zerpa, H. et al. (2013) Eur. J. Pharmacol. 702, 242.